A new RP-HPLC method for iomeprol impurity testing was published on May 15, 2026. The method used a Nanochrom ChromCore AQ C18 column, 245 nm detection, and 10 µL injection volume. It quantified iomeprol and impurities A–E in contrast agent injections. The method showed linearity from LOQ to 200%, with R² values above 0.999. This matters because iomeprol injections need strict impurity control, stability testing, and GMP-ready analytical evidence.
What Technical Method Was Validated for Iomeprol Impurity Testing?
The study validated a stability-indicating RP-HPLC method for iomeprol and five known impurities. It used a 4.6 mm × 250 mm, 5 µm C18 column, 1.0 mL/min flow, 40 °C column temperature, and 245 nm detection. The method used gradient elution with 0.01 mol/L potassium dihydrogen phosphate and water/acetonitrile/2-butanol at 50/45/5.
How Can This RP-HPLC Method Impact Pharmaceutical Quality Control?
The method gives QC labs a practical alternative to LC-MS/MS for routine impurity testing. It reached LOQ values of 0.067–0.135 µg/mL for impurities A–E and iomeprol, equal to about 0.002% of sample concentration. However, the full run time was 55 minutes, including nearly 20 minutes of re-equilibration, which may limit high-throughput batch release testing.
Why Does This News Matter to Pharma Laboratory Professionals?
This news matters because the method links chromatography, stability testing, impurity profiling, and injectable product safety. It supports ICH Q2(R1)-style validation, forced degradation studies, analytical transfer, and long-term impurity trend monitoring for iomeprol APIs and finished injections.
Why Should QC Analysts Care about This RP-HPLC Method?
QC analysts can use this method to monitor iomeprol-related impurities with clear sensitivity, reproducibility, and system suitability data. The study reported peak-area RSD below 1.0% across five injections.
- Track impurities A–E during routine testing.
- Use LOQ-level data for trace impurity control
Why Does This Matter for Analytical Method Validation Teams?
Validation teams get a useful example of specificity, accuracy, precision, robustness, LOD, LOQ, and linearity testing. Recoveries ranged from 96% to 101%, with RSD values below 3%.
- Align validation design with ICH Q2(R1).
- Check robustness across flow, temperature, analyst, instrument, and column changes.
Why is This Important for Injectable Product and QA Teams?
Injectable product teams need strong evidence that impurities and degradation products stay controlled. The study found alkaline degradation risk, slight photolytic sensitivity, and no major degradation under selected oxidative and thermal stress conditions.
- Control pH near neutral formulation conditions.
- Protect iomeprol products from light during storage and transport.
What Result Can This Validated Method Bring for Iomeprol Injections?
The 2026 method can support impurity testing, stability studies, and quality decisions for iomeprol injections. It showed mass balance between 90% and 110% during forced degradation, solution stability for at least 35 hours, and minimum robustness resolution above 3. These data strengthen QC confidence for batch review and GMP documentation.
Strengthen your QC confidence after this RP-HPLC news. Read Pharmuni’s The Hidden Risks in Analytical Method Validation